stearoyl-CoA desaturase 1 (SCD1) mRNA to further define the molecular mechanism for the induction of stearoyl-CoA desaturase by peroxisome proliferators. SCD1 mRNA was analyzed from the livers of BALB/c mice that had been fed diets supplemented with clofibrate or gemfibrozil. Clofibrate was found to induce liver SCD1 mRNA levels 3-fold within 6 hr to a maximum of 22-fold in 30 hr. Gemfibrozil administration resulted in a similar induction pattern. This induction is primarily due to an increase in transcription of the SCD1 gene, as shown by nuclear run-on transcription assays and DNA deletion analysis of transfected SCD1-chloramphenicol acetyltransferase fusion genes. The cis-linked response element for peroxisome proliferator-activated receptor (PPAR) was localized to an AGGTCA consensus sequence between base pairs -664 to -642 of the SCD1 promoter. Clofibratemediated induction of SCD1 mRNA was shown to be independent of polyunsaturated fatty acids, with peroxisome proliferators and arachidonic acid having opposite effects on SCD1 mRNA levels. Additionally, the activation of SCD1 mRNA by clofibrate was inhibited 77% by cycloheximide administration. Levels of liver 13-actin and albumin mRNAs were unchanged by these dietary manipulations. Our data show that hepatic SCD1 gene expression is regulated by PPARs and suggest that peroxisome proliferators and polyunsaturated fatty acids act through distinct mechanisms.
Peroxisome proliferators include structurally distinct compounds such as amphipathic carboxylates, herbicides, and pesticides. These compounds cause hypolipidemia when administered to mice, rats, humans, and other mammals (1) , and, therefore, have the potential to be used in the treatment of hyperlipidemia and hypercholesterolemia. Transcription of peroxisomal (3-oxidation genes and liver cytochrome P450 genes is induced up to 20-fold by peroxisome proliferators (2) (3) (4) , while the transcription of lipogenic genes such as S14 and fatty acid synthase is repressed (5) . Also, the transcription of genes involved in phospholipid biosynthesis is induced, probably as a result of the increase in the size of peroxisomal, mitochondrial, and plasma membranes (6) . These transcriptional effects are presumed to be mediated by peroxisome proliferator-activated receptors (PPARs) (7) . Three PPAR genes (a, ,B, and ry) have been cloned and sequenced in different species: 3 Xenopus (8), 2 mouse (9-11), 1 rat (12) , and 1 human (13) . PPARs are members of the steroid hormone superfamily and have been shown to bind peroxisome proliferator-activated receptor response elements (PPREs) in association with retinoid-X receptors (RXR). PPARs are activated by polyunsaturated fatty acids (PUFAs), as well as peroxisome proliferators. Peroxisome proliferators have been shown to repress the activity of certain lipogenic proteins such as S14 and fatty acid synthase through PPARs (5). In contrast, hepatic stearoyl-CoA desaturase levels are induced in rat liver (14) by clofibrate, a known peroxisome proliferator.
Stearoyl-CoA desaturase (SCD; EC 1.14.99.5) is a key enzyme in fatty acid biosynthesis. It catalyzes the A9-cis desaturation of fatty acyl-CoA substrates, the preferred substrates being palmitoyl-CoA and stearoyl-CoA, which are converted to palmitoleoyl-and oleoyl-CoA respectively. Oleic and palmitoleic acids are the major unsaturated fatty acids in fat depots and membrane phospholipids. The peroxisome proliferator-mediated increase in SCD1 activity corresponds to an increase in the levels of oleic acid incorporated into phospholipids relative to stearic acid (15) . The ratio of stearic to oleic acid is one of the factors influencing cell membrane fluidity and cell-cell interactions (16) . Abnormal alteration of this ratio has been shown to play a role in various disease states such as aging, diabetes, neurological and vascular disease, and carcinogenesis (16) .
The present study examined the effects of clofibrate and gemfibrozil on SCD gene expression in mouse liver. The purpose of this study was to determine the mechanism through which peroxisome proliferators regulate SCD1 gene expression. We show that peroxisome proliferators induce SCD1 mRNA and that this increase is due primarily to an increase in transcription of the SCD1 gene. A PPRE has been localized in the SCD1 promoter that confers peroxisome proliferator responsiveness. Similar to other PPREs, this sequence has a substantial identity to the known consensus sequence. Clofibrate induction of SCD1 mRNA is inhibited by cycloheximide administration, indicating that ongoing protein synthesis is necessary for the induction. Clofibrate and arachidonic acid have opposing effects on SCD1 mRNA levels. This suggests that regulation of the SCD1 gene by peroxisome proliferators and PUFAs occur through distinct mechanisms.
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Biochemistry: Miller and Ntambi All plasmid DNAs were isolated by a modified SDS/NaOH method or the alkaline lysis method (17) . The cDNA for the mPPARa expression vector was obtained from J. Tugwood (Zeneca, Macclesfield, United Kingdom). The plasmids pCAT(An) and TKCAT(An) were obtained from Howard Towle (University of Minnesota). Oligonucleotides were obtained from Eppendorf.
Animals and Treatments. Male BALB/c mice were obtained from the Department of Biochemistry of the University of Wisconsin and from Harlan Sprague Dawley. Mice (4-6 weeks old) were maintained on a complete diet of Purina Formulab Diet 5008 for at least 2 days prior to the start of the experiment. Mice were starved for 24 hr, refed Purina chow diet for 24 hr, starved for 24 hr (18) , and then fed the test diet at intervals shown in the figures and legends. This feeding schedule ensured that the mice ingested the food. In designated experiments the chow diet was supplemented with clofibrate or gemfibrozil, and the fat-free diet was supplemented with triarachidonin, butylated hydroxytoluene (0.1%) as an antioxidant, and clofibrate. Animals were given free access to tap water at all times. In each experiment two mice were treated per sample, and they were processed separately to confirm results by duplication. Each experiment was repeated at least three times. Ten-week-old mice were used to confirm the effect in older animals. Cycloheximide (1 mg/100 g of body weight) was intraperitoneally administered 12 hr prior to sacrifice.
Isolation and Analysis of Liver RNA. Total hepatic RNA was isolated according to Chirgwin et al. (19) . RNase protection analysis was performed according to Melton et al. (20) , using antisense RNA probes for SCD1, albumin, and actin synthesized and hybridized to 15 ,ug of RNA as previously described (21) . The protected RNA hybrids were precipitated with ethanol, analyzed by electrophoresis on a 7% polyacrylamide/7 M urea sequencing gel, and visualized by autoradiography. Relative levels of hybridization were quantified by laser densitometry using multiple exposures to confirm the results. The integrity of the RNA was verified by fractionating 20 ,ug of total liver RNA on a 1% agarose gel containing 6.7% formaldehyde and visualizing the RNA by ethidium bromide staining.
Isolation of Nuclei and in Vitro Run-on Transcription. Nuclei were isolated from fresh liver tissue of mice fed a chow diet with or without 1% clofibrate for various time periods and used for gene transcription studies as previously described (21) .
Construction, Transfection, and Assay of Expression of SCD1-Chloramphenicol Acetyltransferase (CAT) Chimeric Genes. The putative regulatory regions containing 4300, 1200, 600, and 363 bp of the 5' flanking sequence were subcloned into the BamHI sites of the promoterless plasmid pCAT(An) (22) . The deletion constructs were generated by using appropriate restriction enzymes followed by Bal 31. After blunting of the ends with the Klenow fragment of DNA polymerase 1, BamHI linkers were added for insertion into the pCAT(An) plasmid. Oligonucleotides (corresponding to the -664/-642 region of the SCD1 promoter) with BamHI ends were synthesized (5'-GATCCTAGATGTGAAGTTAGACCGAG-3'). They contained the PPRE of the SCD1 gene as shown in Fig. 4 . After annealing of the single-stranded oligonucleotides, the double-stranded PPRE was subcloned into the BamHI site of TKCAT(An). HepG2 cells (106) were seeded onto 6-cm culture dishes in high-glucose (0.45%) Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum 1 day prior to transfection. Transfections were carried out using Lipofectamine with 10 ,ug of reporter plasmid and 1 ,ug of mPPARa expression plasmid. RSVCAT and pCAT(An) were transfected as controls (23) . After overnight transfection, the medium was replaced with high-glucose Williams' medium E (GIBCO/BRL) containing 1 ,uM insulin and 1 nM dexamethasone with or without 150 ,uM clofibrate for 36 hr. Williams' medium E was used to maximize transfection efficiency and to maintain fatty acid-free conditions.
CAT activity was determined as described by Neumann et al. (24) . Results were normalized to protein content.
RESULTS
Induction of SCD1 mRNA by Peroxisome Proliferators.
Hepatic SCD activity was shown to increase with treatment of clofibrate (14) . To determine if the induction was due to an increase in mRNA, we examined the effects of 0.5% and 1% clofibrate administered in a normal chow diet for 36 hr on the accumulation of SCD1 mRNA in mouse liver. SCD1 and f3-actin mRNA levels were analyzed by RNase protection (21, 25) . The protected fragments were separated on a denaturing polyacrylamide gel and the autoradiograms are shown. Clofibrate (0.5% and 1%) significantly induced SCD1 mRNA (Fig.  1A) , without changing levels of f3-actin mRNA (Fig. 1B) , showing that the clofibrate-mediated increase in SCD1 mRNA is specflic.
To show that other peroxisome proliferation-inducing drugs could induce SCD1 mRNA, we examined the effects of 1% and 1.5% gemfibrozil, administered in a chow diet for 36 hr. SCD1 mRNA levels were analyzed by RNase protection. The results show that mouse liver SCD1 mRNA is induced in a dosedependent manner by gemfibrozil (Fig. 1C) diogram is shown (Fig. 2A) . The hybridization signals were quantitated by laser densitometry (Fig. 2B) . Clofibrate induced SCD1 mRNA levels 3-fold within 6 hr and accumulated to a maximum of 22-fold within 30 hr. High-carbohydrate fat-free diet was administered as a control, to reaffirm induction of SCD1 mRNA under these conditions (21 (21) . Fig. 3A shows that SCD1 transcription increased in response to clofibrate. As shown in Fig. 3B , the transcription rate of the SCD1 gene increased 3-fold after 18 hr and 14-fold after 36 hr. The SCD1 transcriptional induction by carbohydrates is 11-fold (21). The pC3 cDNA can hybridize to both SCD1 and SCD2 gene transcripts (21) . Therefore, we also analyzed the SCD300 cDNA, a SCD2-specific probe, to distinguish the expression of the two isoforms. No hybridization occurred to the SCD300 cDNA. Thus, the clofibrate-mediated increase observed was that of SCD1. ,B-Actin was used as a control to ensure that the change in transcription activity measured for the SCD1 gene does not reflect a general increase in transcription in response to clofibrate. pGEM vector was used as a negative control for nonspecific hybridization. No change in transcriptional activity was detected with the f3-actin plasmid cDNA, and radiolabeled RNA from the transcription assays showed no hybridization to pGEM. These results indicate that clofibrate treatment causes a specific increase in SCD1 gene transcription in mouse liver.
Effect of Clofibrate on SCD1-CAT Promoter Constructs. To further demonstrate that the regulation of SCD1 by peroxisome proliferators is transcriptional, fragments of the SCD1 5' flanking region containing putative regulatory elements were cloned into a CAT reporter plasmid for chimeric transfection analysis. Cotransfection experiments were conducted in HepG2 cells with SCD4300CAT, SCD1200CAT, SCD600CAT, and SCD363CAT constructs and a mPPARa expression plasmid. This expression plasmid produces the a form of the mouse PPAR. mPPARa is known to be expressed and to mediate peroxisome proliferator responses in liver. HepG2 cells were chosen because they are easily manipulated in culture and endogenously express SCD1 gene (data not shown). As shown in Fig. 44 there are low levels of PPARa in HepG2 cells. Transient transfection induction may be low compared with the transcriptional increase (Fig. 3) because of a corresponding lack of retinoid-X receptor a. SCD600CAT and SCD363CAT did not respond to cotransfected PPARa or clofibrate. CAT activity of RSVCAT and pCAT(An) did not change in response to clofibrate or the cotransfection of mPPARa, indicating that the clofibratemediated increase in SCD1 CAT activity is specific and is mediated by SCD1 promoter sequences between positions -1200 and -600.
The base pair -660/-642 region of the SCD1 promoter contains a sequence with substantial homology to the AG-GTCA half-site consensus sequence (Fig. 4C) . To demonstrate that this sequence could confer peroxisome proliferator responsiveness, oligonucleotides were synthesized and cloned upstream of the heterologous thymidine kinase promoter construct TKCAT(An). Cotransfection experiments were conducted with this construct (-664/-642 TKCAT) and the mPPARa expression plasmid. As shown in Fig. 4B , transfection of the -664/-642 TKCAT construct resulted in no induction of CAT activity by clofibrate alone, and a 3-fold increase in the presence of the cotransfected PPARa. Both clofibrate and PPARa resulted in a 6-fold induction of CAT activity. CAT activity of RSVCAT and TKCAT(An) did not change in response to clofibrate or the cotransfection of mPPARa, indicating that the clofibrate-mediated increase in SCD1 CAT activity is specific. These results localize the PPRE between nucleotides -664 and -642 of the SCD1 promoter and show that this effect is mediated through a PPAR.
Clofibrate and PUFAs Regulate SCD1 mRNA Levels Independently. Refeeding a fat-free high-carbohydrate diet to fasted mice increases the rate of transcription of the SCD1 gene (21) . This induction is partially caused by the removal of PUFAs from the diet. To our knowledge, SCD1 is the first gene that has been shown to respond differently to PUFAs and peroxisome proliferators. Therefore, an experiment was done to show more distinctly the separate and opposing effects of clofibrate and PUFAs on SCD1 mRNA levels. Mice were fed a chow diet or a fat-free high-carbohydrate diet supplemented with various combinations of clofibrate (1%) and triarachidonin (0.25%, 1%). RNA was isolated after 24 hr of feeding, and SCD1 and actin mRNA levels were measured by RNase protection (Fig. 5 A and C) . A 24-hr time point was chosen because it is intermediate between the maximum effects of PUFAs (approximately 12 hr) and clofibrate. The SCD1 mRNA hybridization signal was quantitated by laser densitometry, and a graph of these results is shown (Fig. SB) .
Addition of clofibrate and triarachidonin to the chow diet resulted in 53% increase over triarachidonin alone. This indicates that clofibrate could overcome the repression of additional PUFAs in the diet.. Clofibrate added to the highcarbohydrate diet resulted in a slight increase in SCD1 mRNA over that diet alone (data not shown). Addition of 0.25% and 1% triarachidonin to the high-carbohydrate diet resulted in 81% and 99% repression, respectively. Addition of clofibrate to the triarachidonin-supplemented high-carbohydrate diets resulted in 36% and 32% recovery, respectively. Other PUFAs, such as trilinolein, showed similar effects (data not shown). Levels of actin mRNA were not significantly affected by these dietary manipulations (Fig. SC) (1996) present study, the mechanism responsible for this induction was investigated. To determine if the induction was due to an increase in mRNA, we examined the effects of clofibrate and gemfibrozil administered in a normal chow diet for 36 hr on the accumulation of SCD1 mRNA in mouse liver. Both drugs activated SCD1 mRNA synthesis equally well (Fig. 1) . A time course study showed that SCD1 mRNA induction was apparent within 6 hr and reached a maximum of 22-fold after 30 hr.
Cycloheximide treatment showed that ongoing protein synthesis is required for SCD1 mRNA induction by peroxisome proliferators (Fig. 2) . Nuclear run-on transcription assays showed that the increase of SCD1 mRNA was a consequence of an increase in the rate of SCD1 gene transcription (Fig. 3) . Transfection analysis revealed that the PPRE was at positions -664/-642 of the SCD1 promoter (Fig. 4) . This element was initially speculated to be present on the basis of sequence homology (11 of 15 base pairs) with the PPRE consensus sequence (28) . Supplementation of a chow diet or fat-free high-carbohydrate diet with clofibrate and/or arachidonic acid showed that clofibrate and PUFAs have opposing effects on SCD1 mRNA levels (Fig. 5) . The response of the SCD1 gene is unlike that of lipogenic genes, such as S14 and fatty acid synthase, which are repressed by both peroxisome proliferators and PUFAs (5) .
Peroxisome proliferation-activating drugs lower blood lipid levels by stimulating increased hepatic uptake of triacylglycerides (1), which, in turn, results in transcriptional regulation of genes involved in lipid homeostasis. The triacylglyceride/ fatty acid balance is influenced by changes in three major liver pathways: peroxisomal ,B-oxidation, fatty acid biosynthesis, and phospholipid biosynthesis. Gene transcription of the enzymes involved in (3-oxidation and phospholipid biosynthesis are induced up to 20-fold in response to these drugs (2-4). To limit fatty acid accumulation, lipogenic enzymes such as acetyl-CoA carboxylase, fatty acid synthase, and S14 are repressed (5, 29, 30) , whereas stearoyl-CoA desaturation, palmitoyl-CoA elongation, and A6 and A5 desaturation activities are induced by administration of peroxisome proliferators (14, 15, 31) .
The observable effects of administering peroxisome proliferators to rodents are increased size of organelles, including peroxisomes, mitochondria, and the endoplasmic reticulum, and enlargement of the liver itself (12, 32 (34) . Therefore, the induction of SCD may be necessary to compensate for a lack of PUFAs in the membrane and to enhance phospholipid biosynthesis. Previous studies have shown that clofibrate results in an increase in 18:1 found in phosphatidylcholine (15) , supporting this hypothesis.
PUFAs activate PPARs and were hypothesized to be the endogenous activator of this orphan receptor (12) . Lipogenic genes, such as S14 and fatty acid synthase, are repressed by both peroxisome proliferators and PUFAs (5, 35) . It has been speculated that there is a PPRE-like binding site in the known PUFA response element of the fatty acid synthase gene. Thus, PPAR and PUFA effects might be mediated through the same trans-acting factor (28, 36 (15) . However, cotransfection data presented here show that PPARa is directly involved in the SCD1 transcriptional induction.
In vivo studies showed activation of peroxisomal (3-oxidation genes was 9-to 15-fold within 1 hr after clofibrate administration, and it increased to a maximum within a few hours (37 to respond to external stimuli. Inability of the cell to maintain an appropriate ratio has been linked to carcinogenesis (16) . Hepatic tumors are induced as a result of long-term peroxisome proliferator administration to mice and rats (1) . This may be due, in part, to an increase in SCD1 activity and an alteration of oleic to stearic acid ratios. All of the implications of changing the activity of SCD are not known. However, the opposing effects of PUFAs and clofibrate on SCD1 transcription have led to new insight into the mechanism of PPAR gene regulation. Further studies will be needed to elucidate the physiological ramifications of induction of SCD1 transcription and to identify the endogenous PPAR ligands.
